Acetylcholine in mind: a neurotransmitter correlate of consciousness?
about
Control of sleep and wakefulnessIon channels gated by acetylcholine and serotonin: structures, biology, and drug discoveryPractical considerations and nuances in anesthesia for patients undergoing deep brain stimulation implantation surgeryMemantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's diseaseNovel interaction between the M4 muscarinic acetylcholine receptor and elongation factor 1A25-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's diseaseNicotinic α7 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortexAcute synaptic modulation by nicotinic agonists in developing cerebellar Purkinje cells of the ratCognitive Impairments Induced by Concussive Mild Traumatic Brain Injury in Mouse Are Ameliorated by Treatment with Phenserine via Multiple Non-Cholinergic and Cholinergic MechanismsNeurokinin-1 receptors in cholinergic neurons of the rat ventral pallidum have a predominantly dendritic distribution that is affected by apomorphine when combined with startle-evoking auditory stimulation.Minds on replay: musical hallucinations and their relationship to neurological disease.Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations.Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning.Short- and long-term habituation of auditory event-related potentials in the rat.Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation.Delta and theta oscillations as risk markers in adolescent offspring of alcoholics.Distinct forms of cholinergic modulation in parallel thalamic sensory pathways.Prefrontal gray matter morphology mediates the association between serum anticholinergicity and cognitive functioning in early course schizophrenia.Basal forebrain acetylcholine release during REM sleep is significantly greater than during waking.Successful use of donepezil for the treatment of dementia with Lewy bodies.Quality of life as an outcome in Alzheimer's disease and other dementias--obstacles and goals.Scutellarin protects against Aβ-induced learning and memory deficits in rats: involvement of nicotinic acetylcholine receptors and cholinesterase.Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's diseaseCognitive enhancement as a pharmacotherapy target for stimulant addictionUncovering genes for cognitive (dys)function and predisposition for alcoholism spectrum disorders: a review of human brain oscillations as effective endophenotypes.Nicotinic Receptors: Role in Addiction and Other Disorders of the Brain.Temporal dynamics of distinct CA1 cell populations during unconscious state induced by ketamine.Cholinergic neuromodulation controls directed temporal communication in neocortex in vitroInvestigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines.Zebrafish Get Connected: Investigating Neurotransmission Targets and Alterations in Chemical Toxicity.Receptor targeting and heterogeneity at interneuronal nicotinic cholinergic synapses in vivo.Brainstem stimulation increases functional connectivity of basal forebrain-paralimbic network in isoflurane-anesthetized ratsDecreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia.Reward, addiction, withdrawal to nicotine.Molecular ontogeny of major neurotransmitter receptor systems in the mammalian central nervous system: norepinephrine, dopamine, serotonin, acetylcholine, and glycine.Modes and models of forebrain cholinergic neuromodulation of cognition.Acetylcholinesterase inhibitors: pharmacology and toxicology.Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody.N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors.
P2860
Q24634619-F3D917AB-7DCB-4ED1-A143-3A12677779E1Q26799689-F98A4261-EF7A-4321-B63A-F6D238048894Q26800073-A6567B08-74C6-4A40-82E5-7D3C5324D8A2Q27025207-19F3F3B7-4915-4BDA-B62F-F3A58DAC735DQ28202533-40B81326-B1F2-4FF1-8BE1-5B56FCE91690Q28287100-33A83A94-D79C-4C0E-B8EA-034F3FDE3F82Q28293779-BBCEED84-B5DB-4C1D-8A05-1B506FF7F43BQ28344406-BC2B1A47-EDC3-49AD-8822-D9BDFB7E1C32Q28552599-2F253427-50F5-450F-98BD-BBCD95369A3EQ28566442-27FC4C97-8E27-40B9-A62F-8861A86CD1E2Q30380073-51107F3C-0A42-4DCC-B517-AC3E4715735AQ30396291-C625E563-67C0-4804-9256-E8B6FF59BD63Q30403978-2C11FCBA-4231-4881-9361-B9D4D7DE1073Q30422037-B340D410-D026-4996-B798-A11694A10135Q30432905-E6307D9F-1047-4AD8-96F2-632E71B85224Q30489795-08CF0067-3283-491A-B6FE-F04B6C9ECC7AQ30499183-C5A49683-4CD8-40E4-9BBF-E63E60DCAEBBQ30501087-D875221A-4F73-4401-BE77-E1CC5AADDA4AQ30529640-83D8B7F7-154B-42DA-9B1F-AFBCA56433D6Q32031945-D42D06C2-BFAA-4B5D-8C94-47BA3B3C87DCQ32052939-E144F587-87C8-4D83-BF82-F812E1CCEA82Q33496593-F7704A35-B29B-4331-852C-F5C3063B951EQ33566782-BE15D512-BD22-495D-88F6-1F41BE23AE65Q33567182-409FFEC6-ED84-4381-8CC5-1E007B851DDFQ33599983-ED06A4B5-B453-4181-809B-003223D0FC81Q33623594-765F5914-B26C-4BA5-B029-E6782BCEB20BQ33635666-69182C97-F4CB-4E05-B752-23796E77AA19Q33774223-BFC03D47-B8C1-488F-A4BB-4E8122547A2BQ33797862-6D142426-67A9-4D13-B3A6-E9621BB10517Q33865755-5BFED821-4C46-4A94-8B34-E3C6CDC39DA7Q33915317-9DB952CC-140C-4798-8C90-C3B83E07329FQ33919096-4CF4CC72-90A5-4E16-A1C3-1C402012DFC5Q34097185-4EFCA42B-58BA-4FF5-B228-B25B88446514Q34163923-159AD186-F86D-4698-834E-0D06D73454D7Q34173418-146F9251-FB44-4D28-91A4-7748C131DBC1Q34238346-D1EE88AF-7458-4B3E-8BF7-D1FAED055F83Q34355481-A7893140-A169-4C2B-83B8-98CFA163F9F9Q34381860-60AFA48A-6ABE-4B78-8090-5000EF7E431DQ34391211-D9BBD96E-FE63-4870-810A-E6CD718FBB79Q34419652-89C65FE8-57D1-44DF-973E-3FB3740A07C6
P2860
Acetylcholine in mind: a neurotransmitter correlate of consciousness?
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Acetylcholine in mind: a neurotransmitter correlate of consciousness?
@ast
Acetylcholine in mind: a neurotransmitter correlate of consciousness?
@en
type
label
Acetylcholine in mind: a neurotransmitter correlate of consciousness?
@ast
Acetylcholine in mind: a neurotransmitter correlate of consciousness?
@en
prefLabel
Acetylcholine in mind: a neurotransmitter correlate of consciousness?
@ast
Acetylcholine in mind: a neurotransmitter correlate of consciousness?
@en
P2093
P1476
Acetylcholine in mind: a neurotransmitter correlate of consciousness?
@en
P2093
P304
P356
10.1016/S0166-2236(98)01361-7
P577
1999-06-01T00:00:00Z